News
-
August 3, 2012
Race against a million deaths begins at Tucson’s C-Path
When I’ll Have Another won the Kentucky Derby in May, no one talked about the hundreds of millions of dollars each year that is lost by the owners of the thousands of horses that lose countless races. Now, imagine a horse race impossibly longer and riskier than the derby, not a mile and a half... -
July 26, 2012
Approval of new drugs slowing
Fewer new prescription drugs will get approved in the U.S. this year than the 30 approved in 2011, a ratings agency forecasts, adding to the many stresses on the pharmaceutical industry. The Food and Drug Administration approved only 14 innovative drugs in the first half of this year, down from 18 in the first half... -
July 10, 2012
Tucson tech: Tucson’s C-Path drug institute looks to boost its future funding
Tucson’s Critical Path Institute recently got some good news – and some noteworthy recognition – when the U.S. Senate gave final approval to a budget reauthorization bill including the Food and Drug Administration partnership program that helps fund the institute. -
May 15, 2012
Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases
The Coalition Against Major Diseases is pooling clinical data to build disease and drug models. -
May 1, 2012
Renewed Focus on Tuberculosis Holds Promise for New Treatments
FDA approved rifampin for the treatment of tuberculosis (TB) in 1971, the same year Intel Corporation invented the first microprocessor. Since then, advances in computer technology have revolutionized the way people live and work. But no additional medications have been approved by FDA for the treatment of Mycobacterium tuberculosis infection—a problem that federal officials and...